153
Participants
Start Date
January 31, 2016
Primary Completion Date
February 28, 2019
Study Completion Date
February 28, 2020
Idarubicin（IDA）
Idarubicin was administered at 15mg/m2/day on days -12 and -10.
Busulfan (BU)
Busulfan was administered at 3.2 mg/kg/day on days -7 to -4.
Cyclophosphamide (CY)
Cyclophosphamide was administered at 60 mg/kg/day on days -3 to -2.
Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou
Third Affiliated Hospital, Sun Yat-Sen University
OTHER
Peking University People's Hospital
OTHER
Zhujiang Hospital
OTHER
Guangzhou First People's Hospital
OTHER
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
OTHER
Nanfang Hospital, Southern Medical University
OTHER